dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Brendel, Karl |
dc.contributor.author | Bekaii-Saab, Tanios S |
dc.contributor.author | Boland, Patrick M |
dc.contributor.author | Dayyani, Farshid |
dc.contributor.author | Macarulla Mercadé, Teresa |
dc.contributor.author | Dean, Andrew |
dc.date.accessioned | 2022-05-30T13:22:40Z |
dc.date.available | 2022-05-30T13:22:40Z |
dc.date.issued | 2021-12 |
dc.identifier.citation | Brendel K, Bekaii-Saab T, Boland PM, Dayyani F, Dean A, Macarulla T, et al. Population Pharmacokinetics of Liposomal Irinotecan in Patients With Cancer and Exposure–Safety Analyses in Patients With Metastatic Pancreatic Cancer. CPT Pharmacometrics Syst Pharmacol. 2021 Dec;10(12):1550–63. |
dc.identifier.issn | 2163-8306 |
dc.identifier.uri | https://hdl.handle.net/11351/7583 |
dc.description | Farmacocinètica; Irinotecan liposomal; Seguretat |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | CPT: Pharmacometrics & Systems Pharmacology;10(12) |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Pàncrees - Càncer - Tractament |
dc.subject | Medicaments antineoplàstics - Farmacocinètica |
dc.subject | Metàstasi |
dc.subject.mesh | Pancreatic Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Antineoplastic Agents |
dc.subject.mesh | /pharmacokinetics |
dc.title | Population pharmacokinetics of liposomal irinotecan in patients with cancer and exposure–safety analyses in patients with metastatic pancreatic cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1002/psp4.12725 |
dc.subject.decs | neoplasias pancreáticas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | antineoplásicos |
dc.subject.decs | /farmacocinética |
dc.relation.publishversion | https://doi.org/10.1002/psp4.12725 SECTIONS |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Brendel K] Ipsen, Les-Ulis, France. [Bekaii-Saab T] Mayo Clinic, Phoenix, Arizona, USA. [Boland PM] Roswell Park Cancer Institute, Buffalo, New York, USA. [Dayyani F] University of California Irvine, Orange, California, USA. [Dean A] St John of God Hospital Subiaco, Perth, Western Australia, Australia. [Macarulla T] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 34750990 |
dc.identifier.wos | 000720681300001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |